Nuwellis Inc vs GraniteShares 2x Long NVDA Daily ETF — how do they compare? Nuwellis Inc trades at $1.41 (market cap $542.80K), while GraniteShares 2x Long NVDA Daily ETF trades at $36.18. The key difference: GraniteShares 2x Long NVDA Daily ETF is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| NUWE | NVDL | |
|---|---|---|
Market Cap | $542.80K | — |
Sector | Technology | Leveraged / Inverse |
52-Week High | $220.50 | $43.02 |
52-Week Low | $1.42 | $21.76 |
Enterprise Value | -$1.27M | — |
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $1.41, down 0.7% on the day, with a bearish technical signal driven by moving averages. The company shows strong revenue growth, with preliminary Q2 2026 revenue up 14% year-over-year, but remains unprofitable with a net income margin of -217.22%. Recent developments include a reverse stock split, new CEO appointment, and expansion of its Aquadex platform into new pediatric markets. Cash flow from operations is negative, though recent financing activities have provided capital.
The outlook is mixed: growth initiatives and analyst support offer potential, but persistent losses and high cash burn pose significant risks. Investors should weigh the company's expansion against its financial sustainability.
NVDL, the GraniteShares 2x Long NVDA Daily ETF, trades at $36.32, up 5.7% in 24 hours, reflecting strong bullish momentum from its underlying asset NVIDIA. Technical indicators show a bullish trend with moving averages supporting upward movement, though the RSI suggests mild overbought conditions. Recent news highlights NVDL's leveraged exposure to NVIDIA's AI-driven growth, with the ETF capturing amplified returns from NVDA's performance, including a 12.66% year-to-date gain as of June 8, 2026, per 24/7 Wall Street.
The outlook for NVDL is tied to NVIDIA's continued dominance in AI chips, with potential for significant gains during bullish phases but high volatility risks due to daily reset leverage. Key risks include compounded losses during NVDA downturns, as seen in a 12% single-day drop on June 5, 2026. Investors should weigh the ETF's amplified returns against its inherent decay in volatile markets.
Trailing returns across standard periods
Latest headlines on both assets
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →NVDL is a leveraged ETF that seeks daily investment results corresponding to 200% (2x) of the daily performance of NVIDIA Corporation (NVDA) stock. It is designed as a tactical trading tool for investors with a strong bullish (long) view on NVDA. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from two times the performance of the NVDA stock.
Read more on NVDL →